Brief: OSE Immunotherapeutics Receives €1.5 Mln In Funding From Bpifrance

Ose Immunotherapeutics SA

20/06/2023 17:04

June 20 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS RECEIVES €1.5 M IN FUNDING FROM
BPIFRANCE
FOR THE DEVELOPMENT OF A COMPANION DIAGNOSTIC FOR THE CANCER
VACCINE TEDOPI® IN NON-SMALL CELL LUNG CANCER
    * A EUR 1.5 MILLION FUNDING FROM "BPIFRANCE - DIRECTION
RÉGIONALE
DE NANTES" AS PART OF AN "RESEARCH AND DEVELOPMENT INNOVATION
LOAN" PROGRAM

Source text for Eikon:  ID:nBwQPPmfa 
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))